{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-07-10T20:23:11.733505+00:00","company":{"ticker":"XRAY","cik":818479,"company_name":"DENTSPLY SIRONA Inc."},"pagination":{"limit":100,"returned":71,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","counterparties":{"contract_counterparty":[{"display_name":"JPMorgan Chase Bank, N.A.","detail":"credit_facility","count":2,"first_seen":"2022-11-10T23:59:59+00:00","last_seen":"2025-12-31T23:59:59+00:00","evidence_fact_ids":[36594,197702]},{"display_name":"Sirona Dental Services GmbH and the noteholders with respect to the Note Purchase Agreement and Guarantee Agreement, dated as of October 27, 2016","detail":"notes_offering","count":1,"first_seen":"2022-11-10T23:59:59+00:00","last_seen":"2022-11-10T23:59:59+00:00","evidence_fact_ids":[197704]},{"display_name":"noteholders party thereto","detail":"notes_offering","count":1,"first_seen":"2025-12-31T23:59:59+00:00","last_seen":"2025-12-31T23:59:59+00:00","evidence_fact_ids":[36595]},{"display_name":"the noteholders with respect to the Note Purchase Agreement, dated as of December 11, 2015","detail":"notes_offering","count":1,"first_seen":"2022-11-10T23:59:59+00:00","last_seen":"2022-11-10T23:59:59+00:00","evidence_fact_ids":[197703]},{"display_name":"the noteholders with respect to the Note Purchase Agreement, dated as of June 24, 2019","detail":"notes_offering","count":1,"first_seen":"2022-11-10T23:59:59+00:00","last_seen":"2022-11-10T23:59:59+00:00","evidence_fact_ids":[197705]}],"lender":[{"display_name":"Goldman Sachs Bank USA","detail":"term_loan","count":1,"first_seen":"2025-03-19T23:59:59+00:00","last_seen":"2025-03-19T23:59:59+00:00","evidence_fact_ids":[123211]},{"display_name":"JPMorgan Chase Bank, N.A. and lenders","detail":"revolving_credit","count":1,"first_seen":"2023-05-12T23:59:59+00:00","last_seen":"2023-05-12T23:59:59+00:00","evidence_fact_ids":[153215]}]},"facts":[{"fact_type":"executive_change","fact_key":"20c219738d","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2026-06-11T12:32:06+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2026-07-20","interim":false,"role":"Executive Vice President & Chief Financial Officer","role_category":"cfo","successor_name":null,"successor_named":false},"claim":"John C. Fortson was appointed as Executive Vice President & Chief Financial Officer at DENTSPLY SIRONA Inc..","evidence_excerpt":"On June 1, 2026, the Board of Directors (the “Board”) of DENTSPLY SIRONA Inc. (the “Company”) appointed John C. Fortson as the Company’s Executive Vice President & Chief Financial Officer, effective as of July 20, 2026 (the “Effective Date”).","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000818479-26-000200","anchor_url":"https://secwatch.observer/filing/0000818479-26-000200#claim-20c219738d","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847926000200/0000818479-26-000200-index.htm"},{"fact_type":"shareholder_vote","fact_key":"70cdda6d53a7eda970f277a2ef6117ace0d29326","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2026-06-04T20:23:44+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2026-06-02","outcome":"passed","proposal_text":"Approval of Amendment No. 2 to the Company’s 2024 Omnibus Incentive Plan (the “2024 Plan”) to increase the number of shares of the Company’s Common Stock issuable under the 2024 Plan by 15,000,000 shares.","proposal_type":"equity_plan","results":[{"broker_non_votes":"14,762,922","subject":null,"votes_abstain":"194,150","votes_against":"27,713,777","votes_for":"139,933,388","votes_withheld":null}]},"claim":"DENTSPLY SIRONA Inc. shareholders approved Approval of Amendment No. 2 to the Company’s 2024 Omnibus Incentive Plan (the “2024 Plan”) to increase the number of shares of the Company’s Common Stock issuable under the 2024 Plan by 15,000,000 shares. at the 2026-06-02 meeting.","evidence_excerpt":"4. Approval of Amendment No. 2 to the Company’s 2024 Omnibus Incentive Plan (the “2024 Plan”) to increase the number of shares of the Company’s Common Stock issuable under the 2024 Plan by 15,000,000 shares.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000818479-26-000165","anchor_url":"https://secwatch.observer/filing/0000818479-26-000165#claim-70cdda6d53a7eda970f277a2ef6117ace0d29326","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847926000165/0000818479-26-000165-index.htm"},{"fact_type":"shareholder_vote","fact_key":"2862b855b43697585ec444ebaba2abb0bf781b18","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2026-06-04T20:23:44+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2026-06-02","outcome":"passed","proposal_text":"Approval, by non-binding advisory vote, of the Company’s executive compensation for 2025.","proposal_type":"say_on_pay","results":[{"broker_non_votes":"14,762,922","subject":null,"votes_abstain":"255,173","votes_against":"9,090,084","votes_for":"158,496,058","votes_withheld":null}]},"claim":"DENTSPLY SIRONA Inc. shareholders approved Approval, by non-binding advisory vote, of the Company’s executive compensation for 2025. at the 2026-06-02 meeting.","evidence_excerpt":"3. Approval, by non-binding advisory vote, of the Company’s executive compensation for 2025.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000818479-26-000165","anchor_url":"https://secwatch.observer/filing/0000818479-26-000165#claim-2862b855b43697585ec444ebaba2abb0bf781b18","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847926000165/0000818479-26-000165-index.htm"},{"fact_type":"shareholder_vote","fact_key":"ff9a52787ca42f691d0df043cc77b88e32ccda0b","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2026-06-04T20:23:44+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2026-06-02","outcome":"passed","proposal_text":"Ratification of appointment of Deloitte and Touche LLP as the Company’s independent registered public accountants for 2026.","proposal_type":"auditor_ratification","results":[{"broker_non_votes":"—","subject":null,"votes_abstain":"105,792","votes_against":"465,064","votes_for":"182,033,381","votes_withheld":null}]},"claim":"DENTSPLY SIRONA Inc. shareholders approved Ratification of appointment of Deloitte and Touche LLP as the Company’s independent registered public accountants for 2026. at the 2026-06-02 meeting.","evidence_excerpt":"2. Ratification of appointment of Deloitte and Touche LLP as the Company’s independent registered public accountants for 2026.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000818479-26-000165","anchor_url":"https://secwatch.observer/filing/0000818479-26-000165#claim-ff9a52787ca42f691d0df043cc77b88e32ccda0b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847926000165/0000818479-26-000165-index.htm"},{"fact_type":"shareholder_vote","fact_key":"7ab646307f4fe39fd72c0dedff12c608726a986a","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2026-06-04T20:23:44+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2026-06-02","outcome":"passed","proposal_text":"Election of twelve directors to serve until the next annual meeting of stockholders or until their respective successors are duly elected and qualified.","proposal_type":"director_election","results":[{"broker_non_votes":"14,762,922","subject":"Michael J. Barber","votes_abstain":"82,953","votes_against":"642,651","votes_for":"167,115,711","votes_withheld":null},{"broker_non_votes":"14,762,922","subject":"James D. Forbes","votes_abstain":"83,652","votes_against":"726,831","votes_for":"167,030,832","votes_withheld":null},{"broker_non_votes":"14,762,922","subject":"Brian T. Gladden","votes_abstain":"76,882","votes_against":"633,358","votes_for":"167,131,075","votes_withheld":null},{"broker_non_votes":"14,762,922","subject":"Betsy D. Holden","votes_abstain":"158,415","votes_against":"23,407,281","votes_for":"144,275,619","votes_withheld":null},{"broker_non_votes":"14,762,922","subject":"Clyde R. Hosein","votes_abstain":"103,506","votes_against":"1,166,383","votes_for":"166,571,426","votes_withheld":null},{"broker_non_votes":"14,762,922","subject":"Gregory T. Lucier","votes_abstain":"151,369","votes_against":"2,723,724","votes_for":"164,966,222","votes_withheld":null},{"broker_non_votes":"14,762,922","subject":"Jonathan J. Mazelsky","votes_abstain":"162,121","votes_against":"3,177,506","votes_for":"164,501,688","votes_withheld":null},{"broker_non_votes":"14,762,922","subject":"Brian P. McKeon","votes_abstain":"82,158","votes_against":"657,813","votes_for":"167,101,344","votes_withheld":null},{"broker_non_votes":"14,762,922","subject":"Daniel T. Scavilla","votes_abstain":"78,433","votes_against":"674,884","votes_for":"167,087,998","votes_withheld":null},{"broker_non_votes":"14,762,922","subject":"Leslie F. Varon","votes_abstain":"175,027","votes_against":"1,611,470","votes_for":"166,054,818","votes_withheld":null},{"broker_non_votes":"14,762,922","subject":"Janet S. Vergis","votes_abstain":"80,721","votes_against":"2,490,769","votes_for":"165,269,825","votes_withheld":null},{"broker_non_votes":"14,762,922","subject":"Donald J. Zurbay","votes_abstain":"213,223","votes_against":"51,059,271","votes_for":"116,568,821","votes_withheld":null}]},"claim":"DENTSPLY SIRONA Inc. shareholders approved Election of twelve directors to serve until the next annual meeting of stockholders or until their respective successors are duly elected and qualified. at the 2026-06-02 meeting.","evidence_excerpt":"The annual meeting of stockholders (the “Annual Meeting”) of DENTSPLY SIRONA Inc. (the “Company”) was held on June 2, 2026. The following matters were voted upon at the Annual Meeting, with the results indicated: 1. Election of twelve directors to serve until the next annual meeting of stockholders or until their respective successors are duly elected and qualified.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000818479-26-000165","anchor_url":"https://secwatch.observer/filing/0000818479-26-000165#claim-7ab646307f4fe39fd72c0dedff12c608726a986a","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847926000165/0000818479-26-000165-index.htm"},{"fact_type":"earnings_release","fact_key":"b4b09ca76c614561f89d062cc9d9e1440e3f2034","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2026-05-05T23:59:59+00:00","payload":{"eps_text":"$1.40 to $1.50","guidance_signal":"reaffirmed","item_codes_triggered":["2.02"],"net_income_text":null,"period_text":"fiscal year 2026","report_date":"2026-05-05","result_type":"guidance_update","revenue_text":"$3.5 billion to $3.6 billion"},"claim":"DENTSPLY SIRONA Inc. reported fiscal year 2026 results: revenue $3.5 billion to $3.6 billion, EPS $1.40 to $1.50. Guidance reaffirmed.","evidence_excerpt":"The Company is maintaining its 2026 outlook for net sales in the range of $3.5 billion to $3.6 billion and adjusted EPS in the range of $1.40 to $1.50.","confidence":0.99,"filing_url":"https://secwatch.observer/filing/0000818479-26-000147","anchor_url":"https://secwatch.observer/filing/0000818479-26-000147#claim-b4b09ca76c614561f89d062cc9d9e1440e3f2034","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847926000147/0000818479-26-000147-index.htm"},{"fact_type":"earnings_release","fact_key":"0f5d7fdee3355bbf145d0fc7665f9ac344628834","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2026-05-05T23:59:59+00:00","payload":{"eps_text":"($0.05)","guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"($10) million","period_text":"first quarter ended March 31, 2026","report_date":"2026-05-05","result_type":"reported_results","revenue_text":"$880 million"},"claim":"DENTSPLY SIRONA Inc. reported first quarter ended March 31, 2026 results: revenue $880 million, net income ($10) million, EPS ($0.05).","evidence_excerpt":"Dentsply Sirona Reports First Quarter 2026 Results News Summary • Reported net sales of $880 million • Delivered GAAP gross margin of 48.5%, GAAP net loss per share of ($0.05) • Achieved adjusted gross margin of 50.7%, adjusted EBITDA margin of 14.7%, adjusted EPS of $0.27","confidence":0.98,"filing_url":"https://secwatch.observer/filing/0000818479-26-000147","anchor_url":"https://secwatch.observer/filing/0000818479-26-000147#claim-0f5d7fdee3355bbf145d0fc7665f9ac344628834","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847926000147/0000818479-26-000147-index.htm"},{"fact_type":"material_agreement","fact_key":"5130b22013b6a453bc06ba0be03ed885cc98ddef","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2025-12-31T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Note Purchase Agreement Amendments","agreement_type":"notes_offering","counterparty":"noteholders party thereto","effective_date":"2025-12-24","item_codes_triggered":["1.01"],"value_text":"Amendments to three note purchase agreements dated December 11, 2015, October 27, 2016, and June 24,"},"claim":"DENTSPLY SIRONA Inc. entered into Note Purchase Agreement Amendments with noteholders party thereto valued at Amendments to three note purchase agreements dated December 11, 2015, October 27, 2016, and June 24, (effective 2025-12-24).","evidence_excerpt":"On December 24, 2025, the Company entered into the following agreements (collectively, the “Note Purchase Agreement Amendments”): a. Note Purchase Agreement Amendment No. 4, dated as of December 24, 2025, by and among the Company and the noteholders party thereto with respect to the Note Purchase Agreement, dated as of December 11, 2015, by and among the Company and the other parties thereto; b. Note Purchase and Guarantee Agreement Amendment No. 4, dated as of December 24, 2025, by and among the Company, DENTSPLY DENTAL B.V. (as successor by merger to Sirona Dental Services GmbH) and the noteholders party thereto with respect to the Note Purchase Agreement and Guarantee Agreement, dated as of October 27, 2016, by and among the Company, Sirona Dental Services GmbH and the other parties thereto; and c. Note Purchase Agreement Amendment No. 4, dated as of December 24, 2025, by and among the Company and the noteholders party thereto with respect to the Note Purchase Agreement, dated as of","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000818479-25-000300","anchor_url":"https://secwatch.observer/filing/0000818479-25-000300#claim-5130b22013b6a453bc06ba0be03ed885cc98ddef","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847925000300/0000818479-25-000300-index.htm"},{"fact_type":"material_agreement","fact_key":"8a9cda608c8f3ab5e3824671bab5ca73723c227c","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2025-12-31T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Second Amendment to Credit Agreement","agreement_type":"credit_facility","counterparty":"JPMorgan Chase Bank, N.A., as administrative agent","effective_date":"2025-12-24","item_codes_triggered":["1.01"],"value_text":"Amendment to revolving credit facility dated May 12, 2023, establishing new financial covenants incl"},"claim":"DENTSPLY SIRONA Inc. entered into Second Amendment to Credit Agreement with JPMorgan Chase Bank, N.A., as administrative agent valued at Amendment to revolving credit facility dated May 12, 2023, establishing new financial covenants incl (effective 2025-12-24).","evidence_excerpt":"On December 24, 2025, DENTSPLY SIRONA Inc. (the “Company”) obtained the consent of the requisite lenders under its revolving credit facility, dated May 12, 2023, with JPMorgan Chase Bank, N.A., as administrative agent, to, among other things, amend certain provisions by entering into the Second Amendment to Credit Agreement, dated as of December 24, 2025 (the “Second Amendment to Credit Agreement”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000818479-25-000300","anchor_url":"https://secwatch.observer/filing/0000818479-25-000300#claim-8a9cda608c8f3ab5e3824671bab5ca73723c227c","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847925000300/0000818479-25-000300-index.htm"},{"fact_type":"debt_financing","fact_key":"42943bc6fc7f1fa81d2034432e0677c472d81bdd","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2025-06-12T23:59:59+00:00","payload":{"counterparty":null,"effective_date":"2025-06-12","event":"incurrence","instrument_type":"senior_notes","interest_rate_text":"8.375% per year","item_codes_triggered":["2.03"],"maturity_text":"September 12, 2055","principal_text":"$550,000,000 aggregate principal amount"},"claim":"DENTSPLY SIRONA Inc. incurred senior notes of $550,000,000 aggregate principal amount at 8.375% per year maturing September 12, 2055.","evidence_excerpt":"On June 12, 2025, DENTSPLY SIRONA Inc. (the “Company”) issued $550,000,000 aggregate principal amount of the Company’s 8.375% Fixed-to-Fixed Reset Rate Junior Subordinated Notes due 2055 (the “Notes).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-25-140055","anchor_url":"https://secwatch.observer/filing/0001193125-25-140055#claim-42943bc6fc7f1fa81d2034432e0677c472d81bdd","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000119312525140055/0001193125-25-140055-index.htm"},{"fact_type":"executive_change","fact_key":"723146c711","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2025-05-29T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2025-05-30","interim":false,"role":"Executive Vice President & Chief Financial Officer","role_category":"cfo","successor_name":null,"successor_named":false},"claim":"Matthew E. Garth was appointed as Executive Vice President & Chief Financial Officer at DENTSPLY SIRONA Inc..","evidence_excerpt":"On May 27, 2025, the Board of Directors (the “Board”) of DENTSPLY SIRONA Inc. (the “Company”) appointed Matthew E. Garth as the Company’s Executive Vice President & Chief Financial Officer, effective as of May 30, 2025 (the “Effective Date”).","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0000818479-25-000086","anchor_url":"https://secwatch.observer/filing/0000818479-25-000086#claim-723146c711","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847925000086/0000818479-25-000086-index.htm"},{"fact_type":"debt_financing","fact_key":"030f16aa2508df271d3fb738c42da6bdefd248b1","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2025-03-19T23:59:59+00:00","payload":{"counterparty":"Goldman Sachs Bank USA","effective_date":"2025-03-19","event":"incurrence","instrument_type":"term_loan","interest_rate_text":"floating rate per annum equal to, at the Company's option, (i) the forward-looki","item_codes_triggered":["2.03"],"maturity_text":"March 18, 2026","principal_text":"$435 million"},"claim":"DENTSPLY SIRONA Inc. incurred term loan of $435 million with Goldman Sachs Bank USA at floating rate per annum equal to, at the Company's option, (i) the forward-looki maturing March 18, 2026.","evidence_excerpt":"with respect to a 364-day $435 million term loan (the “Bridge Loan Facility”). The Company borrowed the entire amount of the Bridge Loan Facility at the closing.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000818479-25-000042","anchor_url":"https://secwatch.observer/filing/0000818479-25-000042#claim-030f16aa2508df271d3fb738c42da6bdefd248b1","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847925000042/0000818479-25-000042-index.htm"},{"fact_type":"executive_change","fact_key":"f1c85e5865","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2025-02-06T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2025-02-05","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Dorothea Wenzel resigned as Director at DENTSPLY SIRONA Inc..","evidence_excerpt":"Dr. Dorothea Wenzel notified the Board of her resignation as a member of the Board, effective immediately.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000818479-25-000013","anchor_url":"https://secwatch.observer/filing/0000818479-25-000013#claim-f1c85e5865","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847925000013/0000818479-25-000013-index.htm"},{"fact_type":"executive_change","fact_key":"a783066e28","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2025-02-06T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2025-02-05","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Daniel T. Scavilla was appointed as Director at DENTSPLY SIRONA Inc..","evidence_excerpt":"the Board appointed Messrs. Michael J. Barber and Daniel T. Scavilla to the Board, effective immediately.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000818479-25-000013","anchor_url":"https://secwatch.observer/filing/0000818479-25-000013#claim-a783066e28","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847925000013/0000818479-25-000013-index.htm"},{"fact_type":"executive_change","fact_key":"4287148914","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2025-02-06T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2025-02-05","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Michael J. Barber was appointed as Director at DENTSPLY SIRONA Inc..","evidence_excerpt":"the Board appointed Messrs. Michael J. Barber and Daniel T. Scavilla to the Board, effective immediately.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000818479-25-000013","anchor_url":"https://secwatch.observer/filing/0000818479-25-000013#claim-4287148914","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847925000013/0000818479-25-000013-index.htm"},{"fact_type":"executive_change","fact_key":"f5c5025e69","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2024-11-07T23:59:59+00:00","payload":{"action":"resign","action_category":"departure","departure_tone":"routine","effective_date":"2024-11-07","interim":false,"role":"Executive Vice President, Chief Financial Officer, principal financial officer, and interim principal accounting officer","role_category":"cfo","successor_name":"Simon D. Campion","successor_named":true},"claim":"Glenn G. Coleman departed as Executive Vice President, Chief Financial Officer, principal financial officer, and interim principal accounting officer at DENTSPLY SIRONA Inc..","evidence_excerpt":"the date upon which Glenn G. Coleman will resign as the Company’s Executive Vice President, Chief Financial Officer, principal financial officer, and interim principal accounting officer, as has been previously disclosed.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000818479-24-000086","anchor_url":"https://secwatch.observer/filing/0000818479-24-000086#claim-f5c5025e69","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847924000086/0000818479-24-000086-index.htm"},{"fact_type":"executive_change","fact_key":"a418288de0","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2024-11-07T23:59:59+00:00","payload":{"action":"appointed","action_category":"role_change","departure_tone":"not_applicable","effective_date":"2024-11-07","interim":true,"role":"interim principal financial officer","role_category":"cfo","successor_name":"Glenn G. Coleman","successor_named":true},"claim":"Simon D. Campion was appointed as interim principal financial officer at DENTSPLY SIRONA Inc..","evidence_excerpt":"Additionally, on November 6, 2024, the Company appointed Simon D. Campion, the Company’s President and Chief Executive Officer and a member of the Company’s Board of Directors, to the additional role of interim principal financial officer","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000818479-24-000086","anchor_url":"https://secwatch.observer/filing/0000818479-24-000086#claim-a418288de0","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847924000086/0000818479-24-000086-index.htm"},{"fact_type":"executive_change","fact_key":"f68541846b","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2024-11-07T23:59:59+00:00","payload":{"action":"appointed","action_category":"role_change","departure_tone":"not_applicable","effective_date":"2024-11-07","interim":false,"role":"Vice President & Chief Accounting Officer","role_category":"other_named_officer","successor_name":"Glenn G. Coleman","successor_named":true},"claim":"Kevin J. Czerney was appointed as Vice President & Chief Accounting Officer at DENTSPLY SIRONA Inc..","evidence_excerpt":"On November 6, 2024, the Company appointed Kevin J. Czerney, currently the Company’s Vice President, Chief Audit Executive, to the role of Vice President & Chief Accounting Officer","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000818479-24-000086","anchor_url":"https://secwatch.observer/filing/0000818479-24-000086#claim-f68541846b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847924000086/0000818479-24-000086-index.htm"},{"fact_type":"executive_change","fact_key":"25bb9156ab","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2024-08-20T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2024-11-07","interim":false,"role":"Executive Vice President, Chief Financial Officer","role_category":"cfo","successor_name":null,"successor_named":false},"claim":"Glenn G. Coleman resigned as Executive Vice President, Chief Financial Officer at DENTSPLY SIRONA Inc..","evidence_excerpt":"On August 15, 2024, Glenn G. Coleman informed DENTSPLY SIRONA Inc. (the “Company”) of his decision to resign as Executive Vice President, Chief Financial Officer and principal accounting officer of the Company effective November 7, 2024, to pursue another opportunity.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000818479-24-000072","anchor_url":"https://secwatch.observer/filing/0000818479-24-000072#claim-25bb9156ab","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847924000072/0000818479-24-000072-index.htm"},{"fact_type":"restructuring_charge","fact_key":"3bb25e49198123737673ad6bbabdb031a0f0634d","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2024-07-31T23:59:59+00:00","payload":{"affected_area":"global workforce","charge_text":"between $40 million and $50 million in non-recurring restructuring charges","effective_date":"2024-07-29","event_type":"restructuring","headcount_text":"net reduction in the Company's global workforce of approximately 2% to 4%","item_codes_triggered":["2.05"]},"claim":"DENTSPLY SIRONA Inc. announced a restructuring with charges of between $40 million and $50 million in non-recurring restructuring charges affecting global workforce (net reduction in the Company's global workforce of approximately 2% to 4%).","evidence_excerpt":"On July 29, 2024, the Board of Directors of the Company approved a plan to restructure the Company’s business to improve operational performance and drive shareholder value creation. The restructuring plan anticipates a net reduction in the Company’s global workforce of approximately 2% to 4%. The proposed changes are subject to co-determination processes with employee representative groups in countries where required. The Company expects to incur between $40 million and $50 million in non-recurring restructuring charges under the plan, primarily related to employee transition, severance payments and employee benefits, which are expected to be expensed and paid in cash in 2024 and 2025.","confidence":0.98,"filing_url":"https://secwatch.observer/filing/0000818479-24-000070","anchor_url":"https://secwatch.observer/filing/0000818479-24-000070#claim-3bb25e49198123737673ad6bbabdb031a0f0634d","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847924000070/0000818479-24-000070-index.htm"},{"fact_type":"executive_change","fact_key":"e72c0e6fae","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2024-07-31T23:59:59+00:00","payload":{"action":"assumed","action_category":"role_change","departure_tone":"not_applicable","effective_date":"2024-08-16","interim":true,"role":"interim principal accounting officer","role_category":"other_named_officer","successor_name":null,"successor_named":false},"claim":"Glenn G. Coleman changed role as interim principal accounting officer at DENTSPLY SIRONA Inc..","evidence_excerpt":"In connection with Mr. Wagner’s resignation, Glenn G. Coleman, Executive Vice President, Chief Financial Officer, will assume the responsibilities of principal accounting officer on an interim basis, effective August 16, 2024.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000818479-24-000070","anchor_url":"https://secwatch.observer/filing/0000818479-24-000070#claim-e72c0e6fae","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847924000070/0000818479-24-000070-index.htm"},{"fact_type":"executive_change","fact_key":"44c3d54b30","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2024-07-31T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2024-08-16","interim":false,"role":"Vice President, Chief Accounting Officer","role_category":"other_named_officer","successor_name":"Glenn G. Coleman","successor_named":true},"claim":"Richard M. Wagner resigned as Vice President, Chief Accounting Officer at DENTSPLY SIRONA Inc..","evidence_excerpt":"Additionally, on July 25, 2024, Richard M. Wagner informed the Company of his decision to resign as Vice President, Chief Accounting Officer of the Company effective August 16, 2024, to pursue another opportunity.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000818479-24-000070","anchor_url":"https://secwatch.observer/filing/0000818479-24-000070#claim-44c3d54b30","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847924000070/0000818479-24-000070-index.htm"},{"fact_type":"executive_change","fact_key":"1f3d9e38a9","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2024-07-31T23:59:59+00:00","payload":{"action":"departed","action_category":"departure","departure_tone":"routine","effective_date":"2024-10-01","interim":false,"role":"Executive Vice President, Chief Business Officer","role_category":"other_named_officer","successor_name":null,"successor_named":false},"claim":"Andreas G. Frank departed as Executive Vice President, Chief Business Officer at DENTSPLY SIRONA Inc..","evidence_excerpt":"On July 31, 2024, as part of the restructuring plan described in Item 2.05 herein, the Company eliminated the position of Executive Vice President, Chief Business Officer which is currently held by Mr. Andreas G. Frank, effective October 1, 2024, or such other date as mutually agreed to between the parties (the “Termination Date”).","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000818479-24-000070","anchor_url":"https://secwatch.observer/filing/0000818479-24-000070#claim-1f3d9e38a9","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847924000070/0000818479-24-000070-index.htm"},{"fact_type":"earnings_release","fact_key":"a1575c559011f4006a6c9da188031b490b439e14","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2024-05-02T23:59:59+00:00","payload":{"eps_text":"$0.09 per share","guidance_signal":"reaffirmed","item_codes_triggered":["2.02"],"net_income_text":"$18 million","period_text":"the first quarter of 2024","report_date":"2024-05-02","result_type":"reported_results","revenue_text":"$953 million"},"claim":"DENTSPLY SIRONA Inc. reported the first quarter of 2024 results: revenue $953 million, net income $18 million, EPS $0.09 per share. Guidance reaffirmed.","evidence_excerpt":"except as shall be expressly set forth by specific reference in such a filing. \n\n--- EX-99.1 (EX-99.1) ---\n\nDentsply Sirona Reports First Quarter 2024 Results • Net sales of $953 million decreased (2.6%), organic sales decreased (1.9%) • GAAP gross margin of 53.1%, GAAP net income of $18 million or $0.09 per share • Adjusted EBITDA margin of 16.8%, adjusted EPS","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000818479-24-000033","anchor_url":"https://secwatch.observer/filing/0000818479-24-000033#claim-a1575c559011f4006a6c9da188031b490b439e14","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847924000033/0000818479-24-000033-index.htm"},{"fact_type":"auditor_change","fact_key":"16a3e47de44bd86bf611ad31c389ff492f351955","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2024-03-07T23:59:59+00:00","payload":{"action":"engagement","auditor_name":"Deloitte & Touche LLP","disagreement_text":null,"effective_date":"2024-03-04","item_codes_triggered":["4.01"],"non_reliance_signal":"none","successor_auditor_name":null},"claim":"DENTSPLY SIRONA Inc. engaged Deloitte & Touche LLP as its auditor.","evidence_excerpt":"(b) Appointment of New Independent Registered Public Accounting Firm As a result of the process noted above, the Committee on March 4, 2024 approved the appointment of Deloitte & Touche LLP (“Deloitte”) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024, and related interim periods, subject to execution of an engagement letter following completion of Deloitte’s customary client acceptance procedures.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000818479-24-000026","anchor_url":"https://secwatch.observer/filing/0000818479-24-000026#claim-16a3e47de44bd86bf611ad31c389ff492f351955","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847924000026/0000818479-24-000026-index.htm"},{"fact_type":"auditor_change","fact_key":"53cd3c9a1b6e53bf2e2d5c4e07e4a8801c6d6d9f","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2024-03-07T23:59:59+00:00","payload":{"action":"dismissal","auditor_name":"PricewaterhouseCoopers LLP","disagreement_text":null,"effective_date":"2024-03-04","item_codes_triggered":["4.01"],"non_reliance_signal":"none","successor_auditor_name":"Deloitte & Touche LLP"},"claim":"DENTSPLY SIRONA Inc. dismissed PricewaterhouseCoopers LLP as its auditor.","evidence_excerpt":"o Item 4.01 Changes in Registrant's Certifying Accountant (a) Dismissal of Former Independent Registered Public Accounting Firm The Audit and Finance Committee (the “Committee”) of the Board of Directors of DENTSPLY SIRONA Inc. (the “Company”) recently conducted a review of the Company’s independent registered public accounting firm for the fiscal year ended December 31, 2024. As a result of this comprehensive selection process, the Committee approved the dismissal of PricewaterhouseCoopers LLP (“PwC”) as the Company’s independent registered public accounting firm on March 4, 2024. PwC was dismissed on March 4, 2024. The reports of PwC on the Company’s consolidated financial statements, which were included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (the “2023 Form 10-K”) and for the fiscal year ended December 31, 2022, as amended (the “2022 Fo","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000818479-24-000026","anchor_url":"https://secwatch.observer/filing/0000818479-24-000026#claim-53cd3c9a1b6e53bf2e2d5c4e07e4a8801c6d6d9f","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847924000026/0000818479-24-000026-index.htm"},{"fact_type":"earnings_release","fact_key":"24e068063efd97745c293422f72f8c68ba6ebe9a","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2024-02-29T23:59:59+00:00","payload":{"eps_text":"$0.32 per diluted share","guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"$67 million","period_text":"fourth quarter 2023","report_date":"2024-02-29","result_type":"reported_results","revenue_text":"$1,012"},"claim":"DENTSPLY SIRONA Inc. reported fourth quarter 2023 results: revenue $1,012, net income $67 million, EPS $0.32 per diluted share.","evidence_excerpt":"Q4 23 Q4 22 YoY FY 23 FY 22 YoY Net Sales $1,012 $983 2.9% $3,965 $3,922 1.1% Gross Profit $522 $517 1.0% $2,086 $2,127 (1.9%) Gross Margin 51.6% 52.6% 52.6% 54.2% Net Income (Loss) Attributable to Dentsply Sirona $67 ($15) NM ($132) ($950) NM Diluted Earnings (Loss) Per Share $0.32 ($0.07) NM ($0.62) ($4.41) NM","confidence":0.99,"filing_url":"https://secwatch.observer/filing/0000818479-24-000015","anchor_url":"https://secwatch.observer/filing/0000818479-24-000015#claim-24e068063efd97745c293422f72f8c68ba6ebe9a","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847924000015/0000818479-24-000015-index.htm"},{"fact_type":"earnings_release","fact_key":"8c25204c04173a8b4da021878b71d668f17db1ed","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2024-02-29T23:59:59+00:00","payload":{"eps_text":"FY24 outlook: organic sales flat to up 1.5%; adjusted EPS of $2.00 to $2.10","guidance_signal":"initiated","item_codes_triggered":["2.02"],"net_income_text":null,"period_text":"FY24 outlook","report_date":"2024-02-29","result_type":"guidance_update","revenue_text":"organic sales flat to up 1.5%"},"claim":"DENTSPLY SIRONA Inc. reported FY24 outlook results: revenue organic sales flat to up 1.5%, EPS FY24 outlook: organic sales flat to up 1.5%; adjusted EPS of $2.00 to $2.10. Guidance initiated.","evidence_excerpt":"FY24 outlook: organic sales flat to up 1.5%; adjusted EPS of $2.00 to $2.10","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000818479-24-000015","anchor_url":"https://secwatch.observer/filing/0000818479-24-000015#claim-8c25204c04173a8b4da021878b71d668f17db1ed","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847924000015/0000818479-24-000015-index.htm"},{"fact_type":"earnings_release","fact_key":"77692fd4bccd5fef5881ebc74002574dc92d97d1","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2024-02-29T23:59:59+00:00","payload":{"eps_text":"$(0.62) per share","guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"Net income (loss) was ($132) million","period_text":"full year 2023","report_date":"2024-02-29","result_type":"reported_results","revenue_text":"Full year 2023 net sales of $3,965 million"},"claim":"DENTSPLY SIRONA Inc. reported full year 2023 results: revenue Full year 2023 net sales of $3,965 million, net income Net income (loss) was ($132) million, EPS $(0.62) per share.","evidence_excerpt":"Full year 2023 net sales of $3,965 million increased 1.1% (organic sales increased 2.2%), compared to the full year of 2022. Net income (loss) was ($132) million, or ($0.62) per share","confidence":0.99,"filing_url":"https://secwatch.observer/filing/0000818479-24-000015","anchor_url":"https://secwatch.observer/filing/0000818479-24-000015#claim-77692fd4bccd5fef5881ebc74002574dc92d97d1","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847924000015/0000818479-24-000015-index.htm"},{"fact_type":"earnings_release","fact_key":"fd20d4cfefc6335d0bc10bac74145b697de9d3ac","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2024-02-29T23:59:59+00:00","payload":{"eps_text":"Q4 GAAP net income of $0.32 per share","guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"Q4 GAAP net income of $67 million","period_text":"fourth quarter and full year 2023","report_date":"2024-02-29","result_type":"reported_results","revenue_text":"Q4 net sales of $1,012 million"},"claim":"DENTSPLY SIRONA Inc. reported fourth quarter and full year 2023 results: revenue Q4 net sales of $1,012 million, net income Q4 GAAP net income of $67 million, EPS Q4 GAAP net income of $0.32 per share.","evidence_excerpt":"Q4 net sales of $1,012 million increased 2.9%, organic sales increased 1.9% • Q4 GAAP net income of $67 million or $0.32 per share, adjusted EPS of $0.44","confidence":0.98,"filing_url":"https://secwatch.observer/filing/0000818479-24-000015","anchor_url":"https://secwatch.observer/filing/0000818479-24-000015#claim-fd20d4cfefc6335d0bc10bac74145b697de9d3ac","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847924000015/0000818479-24-000015-index.htm"},{"fact_type":"executive_change","fact_key":"c3947ab830","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2024-02-29T23:59:59+00:00","payload":{"action":"not stand for re-election","action_category":"departure","departure_tone":"retirement","effective_date":null,"interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Eric K. Brandt departed as Director at DENTSPLY SIRONA Inc..","evidence_excerpt":"Eric K. Brandt notified the Board of Directors (the “Board”) of DENTSPLY SIRONA Inc. (the “Company”) of his intention not to stand for re-election as a Director of the Company","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000818479-24-000017","anchor_url":"https://secwatch.observer/filing/0000818479-24-000017#claim-c3947ab830","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847924000017/0000818479-24-000017-index.htm"},{"fact_type":"earnings_release","fact_key":"6633c47d93f9571ee00e15dedb94fb1f471c2396","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2024-01-09T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"reaffirmed","item_codes_triggered":["2.02"],"net_income_text":null,"period_text":"the full year 2023","report_date":"2024-01-09","result_type":"preliminary_results","revenue_text":null},"claim":"DENTSPLY SIRONA Inc. updated its the full year 2023 guidance (reaffirmed).","evidence_excerpt":"the Company is providing an update on its 2023 full year anticipated financial results","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000818479-24-000004","anchor_url":"https://secwatch.observer/filing/0000818479-24-000004#claim-6633c47d93f9571ee00e15dedb94fb1f471c2396","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847924000004/0000818479-24-000004-index.htm"},{"fact_type":"earnings_release","fact_key":"150b33c887e7bbdd61afa81b2467a08d32c7785f","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2023-11-02T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"lowered","item_codes_triggered":["2.02"],"net_income_text":"($266) million, or ($1.25) per share","period_text":"the third quarter ended September 30, 2023","report_date":"2023-11-02","result_type":"reported_results","revenue_text":"$947 million"},"claim":"DENTSPLY SIRONA Inc. reported the third quarter ended September 30, 2023 results: revenue $947 million, net income ($266) million, or ($1.25) per share. Guidance lowered.","evidence_excerpt":"A copy of the Company's press release is being furnished as Exhibit 99.1 hereto. \n\n--- EX-99.1 (EX-99.1) ---\n\nDentsply Sirona Reports Third Quarter 2023 Results • Net sales of $947 million were flat year-over-year, organic sales decreased (0.3%) • GAAP gross margin of 52.2%, GAAP net loss of ($266) million or ($1.25) per share • Adjusted EBITDA margin of 18.2%,","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000818479-23-000081","anchor_url":"https://secwatch.observer/filing/0000818479-23-000081#claim-150b33c887e7bbdd61afa81b2467a08d32c7785f","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847923000081/0000818479-23-000081-index.htm"},{"fact_type":"executive_change","fact_key":"550e8f7ce9","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2023-11-02T23:59:59+00:00","payload":{"action":"retired","action_category":"departure","departure_tone":"retirement","effective_date":"2023-12-31","interim":false,"role":"Director","role_category":"director","successor_name":"Brian Gladden","successor_named":true},"claim":"Harry M. Jansen Kraemer Jr. retired as Director at DENTSPLY SIRONA Inc..","evidence_excerpt":"the vacancy from Mr. Harry M. Jansen Kraemer Jr.’s retirement on December 31, 2023","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000818479-23-000081","anchor_url":"https://secwatch.observer/filing/0000818479-23-000081#claim-550e8f7ce9","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847923000081/0000818479-23-000081-index.htm"},{"fact_type":"executive_change","fact_key":"dd8be6fbe3","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2023-11-02T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-01-01","interim":false,"role":"Director","role_category":"director","successor_name":"Harry M. Jansen Kraemer Jr.","successor_named":true},"claim":"Brian Gladden was appointed as Director at DENTSPLY SIRONA Inc..","evidence_excerpt":"On October 31, 2023, the Company appointed Mr. Brian Gladden to the Board of Directors of the Company (the “Board”), effective January 1, 2024 to fill the vacancy from Mr. Harry M. Jansen Kraemer Jr.’s retirement on December 31, 2023","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000818479-23-000081","anchor_url":"https://secwatch.observer/filing/0000818479-23-000081#claim-dd8be6fbe3","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847923000081/0000818479-23-000081-index.htm"},{"fact_type":"shareholder_vote","fact_key":"a1258fe8b19584318e7e12d14ade6fa6d0c05aa9","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2023-10-02T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-05-24","outcome":"passed","proposal_text":"Advisory vote on frequency of named executive officer compensation","proposal_type":"say_on_pay_frequency","results":[]},"claim":"DENTSPLY SIRONA Inc. shareholders approved Advisory vote on frequency of named executive officer compensation at the 2023-05-24 meeting.","evidence_excerpt":"On May 24, 2023, DENTSPLY SIRONA Inc. (the “Company”) filed a Current Report on Form 8-K (the “Original Report”) disclosing the results of the Company’s annual meeting of shareholders on May 24, 2023, including that shareholders selected, on a non-binding, advisory basis, every 1 year as the preferred frequency for the advisory vote on named executive officer compensation.","confidence":0.4,"filing_url":"https://secwatch.observer/filing/0000818479-23-000077","anchor_url":"https://secwatch.observer/filing/0000818479-23-000077#claim-a1258fe8b19584318e7e12d14ade6fa6d0c05aa9","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847923000077/0000818479-23-000077-index.htm"},{"fact_type":"executive_change","fact_key":"96266ddee0","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2023-09-29T23:59:59+00:00","payload":{"action":"retire","action_category":"departure","departure_tone":"retirement","effective_date":"2023-12-31","interim":false,"role":null,"role_category":"director","successor_name":null,"successor_named":false},"claim":"Harry M. Jansen Kraemer, Jr. departed as director at DENTSPLY SIRONA Inc..","evidence_excerpt":"On September 27, 2023, Harry M. Jansen Kraemer, Jr. notified the Board of Directors (the “Board”) of DENTSPLY SIRONA Inc. (the “Company”) of his intent to retire from the Board effective December 31, 2023.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0000818479-23-000074","anchor_url":"https://secwatch.observer/filing/0000818479-23-000074#claim-96266ddee0","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847923000074/0000818479-23-000074-index.htm"},{"fact_type":"earnings_release","fact_key":"969dc5135ec2ea705ff94519db97e70f6e8e35ef","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2023-08-02T23:59:59+00:00","payload":{"eps_text":"$0.40 per diluted share","guidance_signal":"raised","item_codes_triggered":["2.02"],"net_income_text":"$86 million","period_text":"second quarter ended June 30, 2023","report_date":"2023-08-02","result_type":"reported_results","revenue_text":"$1,028 million"},"claim":"DENTSPLY SIRONA Inc. reported second quarter ended June 30, 2023 results: revenue $1,028 million, net income $86 million, EPS $0.40 per diluted share. Guidance raised.","evidence_excerpt":"Second quarter net sales of $1,028 million increased 0.5% (organic sales increased 2.3%), compared to $1,023 million in the second quarter of 2022. Net income for the second quarter of 2023 was $86 million, or $0.40 per diluted share, compared to net income of $73 million, or $0.34 per diluted share in the second quarter of 2022.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000818479-23-000052","anchor_url":"https://secwatch.observer/filing/0000818479-23-000052#claim-969dc5135ec2ea705ff94519db97e70f6e8e35ef","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847923000052/0000818479-23-000052-index.htm"},{"fact_type":"governance_change","fact_key":"a25230d6850d2fe85c1d30fe0de6e9865c828bc1","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2023-08-02T23:59:59+00:00","payload":{"change_type":"bylaw_amendment","effective_date":"2023-07-27","item_codes_triggered":["5.03"],"summary_text":"Amended and Restated By-laws to adopt Universal Proxy Rule requirements and conform to recent Delaware law amendments, effective immediately."},"claim":"DENTSPLY SIRONA Inc.: Amended and Restated By-laws to adopt Universal Proxy Rule requirements and conform to recent Delaware law amendments, effective immediately (effective 2023-07-27).","evidence_excerpt":"On July 27, 2023, the Board of Directors (the “Board”) of DENTSPLY SIRONA Inc. (the “Company”) adopted and approved the Seventh Amended and Restated By-laws of the Company (as amended and restated, the “Amended and Restated Bylaws”), effective immediately.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000818479-23-000052","anchor_url":"https://secwatch.observer/filing/0000818479-23-000052#claim-a25230d6850d2fe85c1d30fe0de6e9865c828bc1","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847923000052/0000818479-23-000052-index.htm"},{"fact_type":"shareholder_vote","fact_key":"d6a224daae88e6ad115a9bc6a0a78715fe19eb77","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2023-05-24T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-05-24","outcome":"passed","proposal_text":"Non-binding advisory vote on the frequency of voting on the Company's executive compensation.","proposal_type":"say_on_pay_frequency","results":[{"broker_non_votes":"5,903,386","subject":null,"votes_abstain":"73,949","votes_against":"0","votes_for":"189,699,223","votes_withheld":"0"}]},"claim":"DENTSPLY SIRONA Inc. shareholders approved Non-binding advisory vote on the frequency of voting on the Company's executive compensation. at the 2023-05-24 meeting.","evidence_excerpt":"Non-binding advisory vote on the frequency of voting on the Company's executive compensation.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000818479-23-000040","anchor_url":"https://secwatch.observer/filing/0000818479-23-000040#claim-d6a224daae88e6ad115a9bc6a0a78715fe19eb77","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847923000040/0000818479-23-000040-index.htm"},{"fact_type":"shareholder_vote","fact_key":"49268a14bc8a3820968a84c7136bd73c329af99a","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2023-05-24T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-05-24","outcome":"passed","proposal_text":"Non-binding vote on the Company's executive compensation for 2022.","proposal_type":"say_on_pay","results":[{"broker_non_votes":"5,903,386","subject":null,"votes_abstain":"89,151","votes_against":"18,103,565","votes_for":"175,863,673","votes_withheld":"0"}]},"claim":"DENTSPLY SIRONA Inc. shareholders approved Non-binding vote on the Company's executive compensation for 2022. at the 2023-05-24 meeting.","evidence_excerpt":"Non-binding vote on the Company's executive compensation for 2022.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000818479-23-000040","anchor_url":"https://secwatch.observer/filing/0000818479-23-000040#claim-49268a14bc8a3820968a84c7136bd73c329af99a","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847923000040/0000818479-23-000040-index.htm"},{"fact_type":"shareholder_vote","fact_key":"d6824eff2c6739e25808a8cd84aaa691875cc748","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2023-05-24T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-05-24","outcome":"passed","proposal_text":"Ratification of appointment of PricewaterhouseCoopers LLP as DENTSPLY SIRONA Inc.'s independent registered public accountants for 2023.","proposal_type":"auditor_ratification","results":[{"broker_non_votes":"0","subject":null,"votes_abstain":"43,985","votes_against":"5,860,776","votes_for":"194,055,014","votes_withheld":"0"}]},"claim":"DENTSPLY SIRONA Inc. shareholders approved Ratification of appointment of PricewaterhouseCoopers LLP as DENTSPLY SIRONA Inc.'s independent registered public accountants for 2023. at the 2023-05-24 meeting.","evidence_excerpt":"Ratification of appointment of PricewaterhouseCoopers LLP as DENTSPLY SIRONA Inc.'s independent registered public accountants for 2023.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000818479-23-000040","anchor_url":"https://secwatch.observer/filing/0000818479-23-000040#claim-d6824eff2c6739e25808a8cd84aaa691875cc748","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847923000040/0000818479-23-000040-index.htm"},{"fact_type":"shareholder_vote","fact_key":"b14614df95a20a917f2c3dc7f64144f2e3b140dc","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2023-05-24T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-05-24","outcome":"passed","proposal_text":"Election of eleven directors to serve until the next annual meeting of stockholders or until his or her successor is duly elected and qualified.","proposal_type":"director_election","results":[{"broker_non_votes":"5,903,386","subject":"Eric K. Brandt","votes_abstain":"300,844","votes_against":"22,715,590","votes_for":"171,039,955","votes_withheld":"0"},{"broker_non_votes":"5,903,386","subject":"Simon D. Campion","votes_abstain":"99,065","votes_against":"901,062","votes_for":"193,056,262","votes_withheld":"0"},{"broker_non_votes":"5,903,386","subject":"Willie A. Deese","votes_abstain":"90,528","votes_against":"13,262,454","votes_for":"180,703,407","votes_withheld":"0"},{"broker_non_votes":"5,903,386","subject":"Betsy D. Holden","votes_abstain":"54,345","votes_against":"10,980,260","votes_for":"183,021,784","votes_withheld":"0"},{"broker_non_votes":"5,903,386","subject":"Clyde R. Hosein","votes_abstain":"92,502","votes_against":"2,381,809","votes_for":"191,582,078","votes_withheld":"0"},{"broker_non_votes":"5,903,386","subject":"Harry M. Jansen Kraemer Jr.","votes_abstain":"86,995","votes_against":"4,134,231","votes_for":"189,835,163","votes_withheld":"0"},{"broker_non_votes":"5,903,386","subject":"Gregory T. Lucier","votes_abstain":"93,569","votes_against":"13,189,907","votes_for":"180,772,913","votes_withheld":"0"},{"broker_non_votes":"5,903,386","subject":"Jonathan J. Mazelsky","votes_abstain":"98,494","votes_against":"1,174,164","votes_for":"192,783,731","votes_withheld":"0"},{"broker_non_votes":"5,903,386","subject":"Leslie F. Varon","votes_abstain":"57,705","votes_against":"10,028,668","votes_for":"183,970,016","votes_withheld":"0"},{"broker_non_votes":"5,903,386","subject":"Janet S. Vergis","votes_abstain":"61,153","votes_against":"3,047,335","votes_for":"190,947,901","votes_withheld":"0"},{"broker_non_votes":"5,903,386","subject":"Dorothea Wenzel","votes_abstain":"66,491","votes_against":"2,363,469","votes_for":"191,626,429","votes_withheld":"0"}]},"claim":"DENTSPLY SIRONA Inc. shareholders approved Election of eleven directors to serve until the next annual meeting of stockholders or until his or her successor is duly elected and qualified. at the 2023-05-24 meeting.","evidence_excerpt":"The annual meeting of shareholders of DENTSPLY SIRONA Inc. was held on May 24, 2023.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000818479-23-000040","anchor_url":"https://secwatch.observer/filing/0000818479-23-000040#claim-b14614df95a20a917f2c3dc7f64144f2e3b140dc","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847923000040/0000818479-23-000040-index.htm"},{"fact_type":"debt_financing","fact_key":"891ed9ca534ed06b3ace0f60437c293dd81cba94","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2023-05-12T23:59:59+00:00","payload":{"counterparty":"JPMorgan Chase Bank, N.A. (Administrative Agent) and lenders","effective_date":"2023-05-12","event":"incurrence","instrument_type":"revolving_credit","interest_rate_text":null,"item_codes_triggered":["2.03"],"maturity_text":"May 12, 2028","principal_text":"$700 million"},"claim":"DENTSPLY SIRONA Inc. incurred revolving credit of $700 million with JPMorgan Chase Bank, N.A. (Administrative Agent) and lenders maturing May 12, 2028.","evidence_excerpt":"On May 12, 2023, DENTSPLY SIRONA Inc. (the “Company”) entered into a five-year senior unsecured multicurrency revolving facility (the “Facility”) pursuant to a Credit Agreement (the “Credit Agreement”) with JPMorgan Chase Bank, N.A., as Administrative Agent, Citibank, N.A., as Syndication Agent, Bank of America, N.A., Commerzbank AG, New York Branch, PNC Bank, National Association, TD Bank, N.A., Truist Bank and Wells Fargo Bank, National Association as Co-Documentation Agents, JPMorgan Chase Bank, N.A., and Citibank N.A., as Joint Bookrunners and Joint Leader Arrangers, and the lenders party thereto, for an aggregate principal amount of $700 million, that expires on May 12, 2028.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000818479-23-000038","anchor_url":"https://secwatch.observer/filing/0000818479-23-000038#claim-891ed9ca534ed06b3ace0f60437c293dd81cba94","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847923000038/0000818479-23-000038-index.htm"},{"fact_type":"earnings_release","fact_key":"4c5ff05225590b37599a1d04253e8b5bc9f646c0","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2023-05-03T23:59:59+00:00","payload":{"eps_text":"($0.09) loss per share","guidance_signal":"raised","item_codes_triggered":["2.02"],"net_income_text":"($19) million","period_text":"the first quarter ended March 31, 2023","report_date":"2023-05-03","result_type":"reported_results","revenue_text":"$978 million"},"claim":"DENTSPLY SIRONA Inc. reported the first quarter ended March 31, 2023 results: revenue $978 million, net income ($19) million, EPS ($0.09) loss per share. Guidance raised.","evidence_excerpt":"First quarter net sales of $978 million increased 0.9%, compared to $969 million in the first quarter of 2022. Net loss for the first quarter of 2023 was ($19) million, or ($0.09) loss per share, compared to net income of $69 million, or $0.32 per diluted share in the first quarter of 2022.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000818479-23-000031","anchor_url":"https://secwatch.observer/filing/0000818479-23-000031#claim-4c5ff05225590b37599a1d04253e8b5bc9f646c0","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847923000031/0000818479-23-000031-index.htm"},{"fact_type":"executive_change","fact_key":"d242640146","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2023-04-12T23:59:59+00:00","payload":{"action":"not standing for re-election","action_category":"departure","departure_tone":"routine","effective_date":null,"interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"John P. Groetelaars departed as Director at DENTSPLY SIRONA Inc..","evidence_excerpt":"On April 10, 2023, John P. Groetelaars notified the Board of Directors (the \"Board\") of DENTSPLY SIRONA Inc. (the \"Company\") of his intent not to stand for re-election as a Director of the Company upon expiration of his current term, which expires at the Company's 2023 Annual Meeting of Stockholders.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000818479-23-000026","anchor_url":"https://secwatch.observer/filing/0000818479-23-000026#claim-d242640146","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847923000026/0000818479-23-000026-index.htm"},{"fact_type":"earnings_release","fact_key":"9e9480f387eb78b46bcb6e875d4ffa8134b311c8","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2023-02-28T23:59:59+00:00","payload":{"eps_text":"$1.80 to $2.00","guidance_signal":"initiated","item_codes_triggered":["2.02"],"net_income_text":null,"period_text":"full year 2023","report_date":"2023-02-28","result_type":"guidance_update","revenue_text":"$3.85 - $3.95 billion"},"claim":"DENTSPLY SIRONA Inc. reported full year 2023 results: revenue $3.85 - $3.95 billion, EPS $1.80 to $2.00. Guidance initiated.","evidence_excerpt":"FY23 outlook: net sales of $3.85 - $3.95 billion, organic sales down (1%) to up 2%, adj. EPS range of $1.80 to $2.00","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000818479-23-000013","anchor_url":"https://secwatch.observer/filing/0000818479-23-000013#claim-9e9480f387eb78b46bcb6e875d4ffa8134b311c8","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847923000013/0000818479-23-000013-index.htm"},{"fact_type":"earnings_release","fact_key":"2300df40bdd98dbe57613a2a007af422df40c644","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2023-02-28T23:59:59+00:00","payload":{"eps_text":"($0.07) per diluted share","guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"($15) million","period_text":"the fourth quarter ended December 31, 2022","report_date":"2023-02-28","result_type":"reported_results","revenue_text":"$983 million"},"claim":"DENTSPLY SIRONA Inc. reported the fourth quarter ended December 31, 2022 results: revenue $983 million, net income ($15) million, EPS ($0.07) per diluted share.","evidence_excerpt":"Fourth quarter 2022 net sales of $983 million decreased (10.9%), compared to $1,103 million in the fourth quarter of 2021. Net loss was ($15) million, or ($0.07) per diluted share","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000818479-23-000013","anchor_url":"https://secwatch.observer/filing/0000818479-23-000013#claim-2300df40bdd98dbe57613a2a007af422df40c644","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847923000013/0000818479-23-000013-index.htm"},{"fact_type":"earnings_release","fact_key":"6db49a5c59acb52e755308d2d390b1d6f0ab49aa","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2023-02-28T23:59:59+00:00","payload":{"eps_text":"($4.41) per diluted share","guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"($950) million","period_text":"the fiscal year ended December 31, 2022","report_date":"2023-02-28","result_type":"reported_results","revenue_text":"$3,922 million"},"claim":"DENTSPLY SIRONA Inc. reported the fiscal year ended December 31, 2022 results: revenue $3,922 million, net income ($950) million, EPS ($4.41) per diluted share.","evidence_excerpt":"Full year 2022 net sales of $3,922 million decreased (7.3%), compared to $4,231 million for the full year of 2021. Net loss was ($950) million, or ($4.41) per diluted share","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000818479-23-000013","anchor_url":"https://secwatch.observer/filing/0000818479-23-000013#claim-6db49a5c59acb52e755308d2d390b1d6f0ab49aa","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847923000013/0000818479-23-000013-index.htm"},{"fact_type":"restructuring_charge","fact_key":"757b0fd748e67fccefcb7fbfeabe9b254c42afa8","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2023-02-16T23:59:59+00:00","payload":{"affected_area":"DENTSPLY SIRONA Inc. global business","charge_text":"up to $165 million in one-time charges, comprising $130 million in restructuring expenditures and charges, the majority of which will be expensed as cash expend","effective_date":"2023-02-14","event_type":"restructuring","headcount_text":"reduction in the Company's global workforce of approximately 8% to 10%","item_codes_triggered":["2.05"]},"claim":"DENTSPLY SIRONA Inc. announced a restructuring with charges of up to $165 million in one-time charges, comprising $130 million in restructuring expenditures and charges, the majority of which will be expensed as cash expend affecting DENTSPLY SIRONA Inc. global business (reduction in the Company's global workforce of approximately 8% to 10%).","evidence_excerpt":"savings. The Board of Directors and management of the Company developed the restructuring plan with the help of leading third party advisors. The Company expects to incur up to $165 million in one-time charges, comprising $130 million in restructuring expenditures and charges, the majority of which will be expensed as cash expenditures in 2023, primarily related to","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000818479-23-000006","anchor_url":"https://secwatch.observer/filing/0000818479-23-000006#claim-757b0fd748e67fccefcb7fbfeabe9b254c42afa8","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847923000006/0000818479-23-000006-index.htm"},{"fact_type":"earnings_release","fact_key":"88d6b8b3b9d33ad355ed2dcb595b7a7e6eba528c","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2023-01-11T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":null,"period_text":"the year ended December 31, 2022","report_date":"2023-01-11","result_type":"preliminary_results","revenue_text":null},"claim":"DENTSPLY SIRONA Inc. reported preliminary financial results for the year ended December 31, 2022.","evidence_excerpt":"Based on preliminary financial information, the Company anticipates its estimated net sales for the year ended December 31, 2022 will be above the high end of its previously provided outlook range of $3.85 billion to $3.88 billion and reaffirms preliminary expectations for adjusted earnings per share (“EPS”) to be in the range of $1.90 to $2.00.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000818479-23-000003","anchor_url":"https://secwatch.observer/filing/0000818479-23-000003#claim-88d6b8b3b9d33ad355ed2dcb595b7a7e6eba528c","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847923000003/0000818479-23-000003-index.htm"},{"fact_type":"earnings_release","fact_key":"cd301d549798ff5213016f6ddb32aad45ac0152c","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2022-11-14T23:59:59+00:00","payload":{"eps_text":"($5.01) loss per diluted share","guidance_signal":"unknown","item_codes_triggered":["2.02"],"net_income_text":"($1,077) million","period_text":"the third quarter ended September 30, 2022","report_date":"2022-11-14","result_type":"reported_results","revenue_text":"$947 million"},"claim":"DENTSPLY SIRONA Inc. reported the third quarter ended September 30, 2022 results: revenue $947 million, net income ($1,077) million, EPS ($5.01) loss per diluted share.","evidence_excerpt":"Charlotte, N.C., November 14, 2022 - DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the \"Company\") (Nasdaq: XRAY) today announced its financial results for the third quarter of 2022. Third quarter net sales of $947 million decreased (8.9%), compared to $1,040 million in the third quarter of 2021. Foreign currency translation negatively impacted sales by (8.2%). Net loss for the third quarter of 2022 was ($1,077) million, or ($5.01) loss per diluted share, compared to $84 million, or $0.38 per diluted share in the third quarter of 2021.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000818479-22-000116","anchor_url":"https://secwatch.observer/filing/0000818479-22-000116#claim-cd301d549798ff5213016f6ddb32aad45ac0152c","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847922000116/0000818479-22-000116-index.htm"},{"fact_type":"material_agreement","fact_key":"b346985995f6ccd9ab0875d71b9faf3cdee6549d","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2022-11-10T23:59:59+00:00","payload":{"action":"amendment","agreement_name":"Note Purchase Agreement Amendment No. 2 and Consent","agreement_type":"notes_offering","counterparty":"the noteholders with respect to the Note Purchase Agreement, dated as of June 24, 2019","effective_date":"2022-11-05","item_codes_triggered":["1.01"],"value_text":null},"claim":"DENTSPLY SIRONA Inc. amended Note Purchase Agreement Amendment No. 2 and Consent with the noteholders with respect to the Note Purchase Agreement, dated as of June 24, 2019 (effective 2022-11-05).","evidence_excerpt":"c. Note Purchase Agreement Amendment No. 2 and Consent, dated as of November 5, 2022, by and among the Company and the noteholders with respect to the Note Purchase Agreement, dated as of June 24, 2019","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000818479-22-000113","anchor_url":"https://secwatch.observer/filing/0000818479-22-000113#claim-b346985995f6ccd9ab0875d71b9faf3cdee6549d","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847922000113/0000818479-22-000113-index.htm"},{"fact_type":"material_agreement","fact_key":"8f4521cffd642e493b0f25909c866f169e17f220","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2022-11-10T23:59:59+00:00","payload":{"action":"amendment","agreement_name":"Note Purchase and Guarantee Agreement Amendment No. 2 and Consent","agreement_type":"notes_offering","counterparty":"Sirona Dental Services GmbH and the noteholders with respect to the Note Purchase Agreement and Guarantee Agreement, dated as of October 27, 2016","effective_date":"2022-11-05","item_codes_triggered":["1.01"],"value_text":null},"claim":"DENTSPLY SIRONA Inc. amended Note Purchase and Guarantee Agreement Amendment No. 2 and Consent with Sirona Dental Services GmbH and the noteholders with respect to the Note Purchase Agreement and Guarantee Agreement, dated as of October 27, 2016 (effective 2022-11-05).","evidence_excerpt":"b. Note Purchase and Guarantee Agreement Amendment No. 2 and Consent, dated as of November 5, 2022, by and among the Company, Sirona Dental Services GmbH and the noteholders with respect to the Note Purchase Agreement and Guarantee Agreement, dated as of October 27, 2016","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000818479-22-000113","anchor_url":"https://secwatch.observer/filing/0000818479-22-000113#claim-8f4521cffd642e493b0f25909c866f169e17f220","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847922000113/0000818479-22-000113-index.htm"},{"fact_type":"material_agreement","fact_key":"b6e1c839a17ccfdcf2dfa7705e2c936e8c802a36","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2022-11-10T23:59:59+00:00","payload":{"action":"amendment","agreement_name":"Note Purchase Agreement Amendment No. 2 and Consent","agreement_type":"notes_offering","counterparty":"the noteholders with respect to the Note Purchase Agreement, dated as of December 11, 2015","effective_date":"2022-11-05","item_codes_triggered":["1.01"],"value_text":null},"claim":"DENTSPLY SIRONA Inc. amended Note Purchase Agreement Amendment No. 2 and Consent with the noteholders with respect to the Note Purchase Agreement, dated as of December 11, 2015 (effective 2022-11-05).","evidence_excerpt":"On November 5, 2022, the Company entered into the following agreements (collectively, the “Consent Agreements”): a. Note Purchase Agreement Amendment No. 2 and Consent, dated as of November 5, 2022, by and among the Company and the noteholders with respect to the Note Purchase Agreement, dated as of December 11, 2015","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000818479-22-000113","anchor_url":"https://secwatch.observer/filing/0000818479-22-000113#claim-b6e1c839a17ccfdcf2dfa7705e2c936e8c802a36","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847922000113/0000818479-22-000113-index.htm"},{"fact_type":"material_agreement","fact_key":"fb5b776305020e52fb7bc8951257f5508413068e","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2022-11-10T23:59:59+00:00","payload":{"action":"amendment","agreement_name":"Credit Agreement","agreement_type":"credit_facility","counterparty":"JPMorgan Chase Bank, N.A., as administrative agent","effective_date":"2022-11-04","item_codes_triggered":["1.01"],"value_text":null},"claim":"DENTSPLY SIRONA Inc. amended Credit Agreement with JPMorgan Chase Bank, N.A., as administrative agent (effective 2022-11-04).","evidence_excerpt":"On November 4, 2022, DENTSPLY SIRONA Inc. (the “Company”) obtained the consent of the requisite lenders under its revolving credit facility, dated July 27, 2018, with JPMorgan Chase Bank, N.A., as administrative agent (the “Credit Agreement”), to further extend the time period for delivery of the Company’s unaudited financial statements for the fiscal quarter ended June 30, 2022","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000818479-22-000113","anchor_url":"https://secwatch.observer/filing/0000818479-22-000113#claim-fb5b776305020e52fb7bc8951257f5508413068e","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847922000113/0000818479-22-000113-index.htm"},{"fact_type":"earnings_release","fact_key":"79b18d59247e63035e524f60ccdc37801296f32a","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2022-11-01T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"initiated","item_codes_triggered":["2.02"],"net_income_text":null,"period_text":"third quarter ended September 30, 2022","report_date":"2022-11-01","result_type":"preliminary_results","revenue_text":"approximately $947 million"},"claim":"DENTSPLY SIRONA Inc. reported third quarter ended September 30, 2022 results: revenue approximately $947 million. Guidance initiated.","evidence_excerpt":"On a preliminary basis, the Company expects that third quarter 2022 Net sales will be approximately $947 million (representing a slight decline in organic sales versus the prior year). Relative to the prior year period, these results reflect foreign exchange headwinds, global supply chain challenges, and softer volumes in the U.S. and China. Based on expected demand trends and foreign exchange impacts, the Company expects sequential Net sales to decline low-single digits in the fourth quarter 2022.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001140361-22-039283","anchor_url":"https://secwatch.observer/filing/0001140361-22-039283#claim-79b18d59247e63035e524f60ccdc37801296f32a","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000114036122039283/0001140361-22-039283-index.htm"},{"fact_type":"restructuring_charge","fact_key":"7ed15e1132ebef28f0f7d753747e88ceb1d7ee77","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2022-11-01T23:59:59+00:00","payload":{"affected_area":"goodwill and intangible assets","charge_text":"between $1.0 billion and $1.3 billion","effective_date":null,"event_type":"impairment","headcount_text":null,"item_codes_triggered":["2.06"]},"claim":"DENTSPLY SIRONA Inc. announced a impairment with charges of between $1.0 billion and $1.3 billion affecting goodwill and intangible assets.","evidence_excerpt":"The Company estimates that the pre-tax non-cash goodwill and intangible assets impairment charge will be between $1.0 billion and $1.3 billion.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001140361-22-039283","anchor_url":"https://secwatch.observer/filing/0001140361-22-039283#claim-7ed15e1132ebef28f0f7d753747e88ceb1d7ee77","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000114036122039283/0001140361-22-039283-index.htm"},{"fact_type":"executive_change","fact_key":"4cf4ae5990","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2022-09-22T23:59:59+00:00","payload":{"action":null,"action_category":"role_change","departure_tone":"not_applicable","effective_date":"2022-09-26","interim":true,"role":"Interim Chief Financial Officer","role_category":"cfo","successor_name":"Glenn G. Coleman","successor_named":true},"claim":"Barbara Bodem changed role as Interim Chief Financial Officer at DENTSPLY SIRONA Inc..","evidence_excerpt":"Mr. Coleman will succeed Barbara Bodem who has served as Interim Chief Financial Officer since May 6, 2022; however, the Company and Ms. Bodem entered into an amendment to her employment agreement, dated as of September 22, 2022, pursuant to which Ms. Bodem will continue her employment with the Company as an advisor to Mr. Coleman until October 24, 2022.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000818479-22-000099","anchor_url":"https://secwatch.observer/filing/0000818479-22-000099#claim-4cf4ae5990","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847922000099/0000818479-22-000099-index.htm"},{"fact_type":"executive_change","fact_key":"6d00bbbf54","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2022-09-22T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2022-09-26","interim":false,"role":"Executive Vice President and Chief Financial Officer","role_category":"cfo","successor_name":null,"successor_named":false},"claim":"Glenn G. Coleman was appointed as Executive Vice President and Chief Financial Officer at DENTSPLY SIRONA Inc..","evidence_excerpt":"On September 22, 2022, the Company appointed Glenn G. Coleman as Executive Vice President and Chief Financial Officer of the Company effective as of September 26, 2022","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000818479-22-000099","anchor_url":"https://secwatch.observer/filing/0000818479-22-000099#claim-6d00bbbf54","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847922000099/0000818479-22-000099-index.htm"},{"fact_type":"executive_change","fact_key":"34d6286e84","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2022-09-02T23:59:59+00:00","payload":{"action":"mutually agreed upon separation","action_category":"departure","departure_tone":"routine","effective_date":"2022-09-30","interim":false,"role":"Senior Vice President, Chief Commercial Officer","role_category":"other_named_officer","successor_name":null,"successor_named":false},"claim":"Walter Petersohn departed as Senior Vice President, Chief Commercial Officer at DENTSPLY SIRONA Inc..","evidence_excerpt":"On September 1, 2022, DENTSPLY SIRONA Inc. (the “Company”) and Walter Petersohn, the Company’s Senior Vice President, Chief Commercial Officer, mutually agreed upon the separation of Mr. Petersohn from the Company, effective September 30, 2022 (the “Termination Date”).","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000818479-22-000094","anchor_url":"https://secwatch.observer/filing/0000818479-22-000094#claim-34d6286e84","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847922000094/0000818479-22-000094-index.htm"},{"fact_type":"executive_change","fact_key":"55be85501b","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2022-08-25T23:59:59+00:00","payload":{"action":"succeeded","action_category":"role_change","departure_tone":"routine","effective_date":"2022-09-12","interim":false,"role":"Interim Chief Executive Officer","role_category":"ceo","successor_name":"Simon D. Campion","successor_named":true},"claim":"John P. Groetelaars changed role as Interim Chief Executive Officer at DENTSPLY SIRONA Inc..","evidence_excerpt":"As of the Effective Date, Mr. Campion will succeed John P. Groetelaars, who has served as Interim Chief Executive Officer since April 16, 2022, and Mr. Groetelaars will continue as a non-executive director of the Company.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000818479-22-000089","anchor_url":"https://secwatch.observer/filing/0000818479-22-000089#claim-55be85501b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847922000089/0000818479-22-000089-index.htm"},{"fact_type":"executive_change","fact_key":"b7dbb9d4b3","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2022-08-25T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2022-09-12","interim":false,"role":"President and Chief Executive Officer","role_category":"ceo","successor_name":null,"successor_named":false},"claim":"Simon D. Campion was appointed as President and Chief Executive Officer at DENTSPLY SIRONA Inc..","evidence_excerpt":"On August 22, 2022, DENTSPLY SIRONA Inc. (the “Company”) appointed Simon D. Campion as the President and Chief Executive Officer of the Company and as a member of the Company’s Board of Directors (the “Board”), in each case effective as of September 12, 2022, or such other date as mutually agreed between the Company and Mr. Campion (the “Effective Date”).","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000818479-22-000089","anchor_url":"https://secwatch.observer/filing/0000818479-22-000089#claim-b7dbb9d4b3","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847922000089/0000818479-22-000089-index.htm"},{"fact_type":"executive_change","fact_key":"c63b4513d2","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2022-08-09T23:59:59+00:00","payload":{"action":"hired","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2022-08-15","interim":false,"role":"Chief Accounting Officer","role_category":"other_named_officer","successor_name":null,"successor_named":false},"claim":"Richard M. Wagner was appointed as Chief Accounting Officer at DENTSPLY SIRONA Inc..","evidence_excerpt":"On August 9, 2022, the Company hired Richard M. Wagner to serve as its Chief Accounting Officer, as well as the principal accounting officer for purposes of the Company’s filings with the Securities and Exchange Commission, which appointment will be effective August 15, 2022.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000818479-22-000080","anchor_url":"https://secwatch.observer/filing/0000818479-22-000080#claim-c63b4513d2","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847922000080/0000818479-22-000080-index.htm"},{"fact_type":"executive_change","fact_key":"e7a1c69e03","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2022-08-09T23:59:59+00:00","payload":{"action":"separated","action_category":"departure","departure_tone":"routine","effective_date":"2022-09-02","interim":false,"role":"Chief Accounting Officer","role_category":"other_named_officer","successor_name":"Richard M. Wagner","successor_named":true},"claim":"Ranjit S. Chadha departed as Chief Accounting Officer at DENTSPLY SIRONA Inc..","evidence_excerpt":"On August 4, 2022, DENTSPLY SIRONA Inc. (the “Company”) and Ranjit S. Chadha, the Company’s Chief Accounting Officer, mutually agreed upon the separation of Mr. Chadha from the Company, effective September 2, 2022","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000818479-22-000080","anchor_url":"https://secwatch.observer/filing/0000818479-22-000080#claim-e7a1c69e03","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847922000080/0000818479-22-000080-index.htm"},{"fact_type":"executive_change","fact_key":"f0bb95f1e5","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2022-04-19T23:59:59+00:00","payload":{"action":"will become","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2022-05-06","interim":true,"role":"Interim Chief Financial Officer","role_category":"cfo","successor_name":null,"successor_named":false},"claim":"Barbara W. Bodem was appointed as Interim Chief Financial Officer at DENTSPLY SIRONA Inc..","evidence_excerpt":"Additionally, effective on the earlier of (i) the effective date of termination of employment of the individual who was serving as the Company’s Chief Financial Officer and (ii) the close of business on May 6, 2022, Barbara W. Bodem will become the Company’s Interim Chief Financial Officer and principal financial officer.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000818479-22-000031","anchor_url":"https://secwatch.observer/filing/0000818479-22-000031#claim-f0bb95f1e5","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847922000031/0000818479-22-000031-index.htm"},{"fact_type":"executive_change","fact_key":"f0a42059b7","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2022-04-19T23:59:59+00:00","payload":{"action":"named","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2022-04-19","interim":true,"role":"Interim Chief Executive Officer","role_category":"ceo","successor_name":null,"successor_named":false},"claim":"John P. Groetelaars was named as Interim Chief Executive Officer at DENTSPLY SIRONA Inc..","evidence_excerpt":"Effective immediately, John P. Groetelaars, who serves as a member of the Board of Directors of the Company, has been named Interim Chief Executive Officer and principal executive officer.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000818479-22-000031","anchor_url":"https://secwatch.observer/filing/0000818479-22-000031#claim-f0a42059b7","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847922000031/0000818479-22-000031-index.htm"},{"fact_type":"executive_change","fact_key":"1dab8bda44","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2022-04-19T23:59:59+00:00","payload":{"action":"terminated","action_category":"departure","departure_tone":"termination","effective_date":"2022-04-19","interim":false,"role":"Chief Executive Officer","role_category":"ceo","successor_name":"John P. Groetelaars","successor_named":true},"claim":"Donald M. Casey Jr. was terminated as Chief Executive Officer at DENTSPLY SIRONA Inc..","evidence_excerpt":"On April 19, 2022, the Company announced that Donald M. Casey Jr. has been terminated as the Company’s Chief Executive Officer and has ceased to serve as a member of the Board of Directors of the Company, effective as of April 19, 2022.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000818479-22-000031","anchor_url":"https://secwatch.observer/filing/0000818479-22-000031#claim-1dab8bda44","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847922000031/0000818479-22-000031-index.htm"},{"fact_type":"executive_change","fact_key":"6b9a7c4648","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2022-04-11T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2022-05-06","interim":false,"role":"Executive Vice President and Chief Financial Officer","role_category":"cfo","successor_name":null,"successor_named":false},"claim":"Jorge M. Gomez resigned as Executive Vice President and Chief Financial Officer at DENTSPLY SIRONA Inc..","evidence_excerpt":"Jorge M. Gomez, Executive Vice President and Chief Financial Officer has resigned from his position with the Company, effective May 6, 2022, to assume a chief financial officer position at another public company.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0000818479-22-000026","anchor_url":"https://secwatch.observer/filing/0000818479-22-000026#claim-6b9a7c4648","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847922000026/0000818479-22-000026-index.htm"},{"fact_type":"executive_change","fact_key":"bf366eeded","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2022-04-06T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2022-04-05","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"John Groetelaars was appointed as Director at DENTSPLY SIRONA Inc..","evidence_excerpt":"Effective April 5, 2022, DENTSPLY SIRONA Inc. (the “Company”) appointed Mr. John Groetelaars to the Board of Directors of the Company (the “Board”) and expanded the size of the Board from eleven members to twelve members.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0000818479-22-000021","anchor_url":"https://secwatch.observer/filing/0000818479-22-000021#claim-bf366eeded","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847922000021/0000818479-22-000021-index.htm"},{"fact_type":"executive_change","fact_key":"a4d9b37741","cik":818479,"ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2022-02-24T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2022-02-22","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Dr. Dorothea Wenzel was appointed as Director at DENTSPLY SIRONA Inc..","evidence_excerpt":"Effective February 22, 2022, DENTSPLY SIRONA Inc. (the “Company”) appointed Dr. Dorothea Wenzel to the Board of Directors of the Company (the “Board”) and expanded the size of the Board from ten members to eleven members.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000818479-22-000007","anchor_url":"https://secwatch.observer/filing/0000818479-22-000007#claim-a4d9b37741","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847922000007/0000818479-22-000007-index.htm"}]}